Virtus Investment Advisers’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $430K | Buy |
966
+193
| +25% | +$85.9K | 0.15% | 212 |
|
|
2025
Q1 | $375K | Buy |
+773
| New | +$375K | 0.1% | 219 |
|
|
2023
Q1 | – | Sell |
-1,317
| Closed | -$380K | – | 343 |
|
|
2022
Q4 | $380K | Hold |
1,317
| – | – | 0.25% | 123 |
|
|
2022
Q3 | $381K | Buy |
+1,317
| New | +$381K | 0.18% | 121 |
|
|
2018
Q1 | – | Sell |
-1,069
| Closed | -$160K | – | 425 |
|
|
2017
Q4 | $160K | Sell |
1,069
-17
| -2% | -$2.54K | 0.02% | 422 |
|
|
2017
Q3 | $165K | Sell |
1,086
-134
| -11% | -$20.4K | 0.02% | 432 |
|
|
2017
Q2 | $157K | Sell |
1,220
-104
| -8% | -$13.4K | 0.02% | 448 |
|
|
2017
Q1 | $145K | Buy |
+1,324
| New | +$145K | 0.01% | 429 |
|
|
2016
Q4 | – | Sell |
-5,279
| Closed | -$460K | – | 527 |
|
|
2016
Q3 | $460K | Buy |
+5,279
| New | +$460K | 0.03% | 366 |
|